SINOPHARM GROUP CO. LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.95 HKD | -1.57% |
|
+2.09% | +7.33% |
| May. 15 | China Grants Registration Approval for Shanghai Shyndec Pharmaceutical Unit's Flu Injection | MT |
| May. 14 | China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 649B 89.87B 701B | Sales 2025 * | 707B 97.89B 764B | Capitalization | 64.39B 8.92B 69.6B |
|---|---|---|---|---|---|
| Net income 2024 * | 9.63B 1.33B 10.41B | Net income 2025 * | 10.59B 1.47B 11.45B | EV / Sales 2024 * | 0.12 x |
| Net Debt 2024 * | 11.49B 1.59B 12.42B | Net Debt 2025 * | 9.36B 1.3B 10.11B | EV / Sales 2025 * | 0.1 x |
| P/E ratio 2024 * |
6.68
x | P/E ratio 2025 * |
6.08
x | Employees | 115,959 |
| Yield 2024 * |
4.53% | Yield 2025 * |
4.98% | Free-Float | 42.99% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | -1.11% | ||
| 1 week | +7.47% | ||
| Current month | +12.40% | ||
| 1 month | +13.08% | ||
| 3 months | +8.25% | ||
| 6 months | +13.43% | ||
| Current year | +9.05% |
1 week
20.75
22.95
1 month
19.0622.95
Current year
17.4423.00
1 year
17.4427.60
3 years
14.6028.45
5 years
14.6030.45
10 years
14.6045.65
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Liu
PSD | President | 55 | 09-01-08 |
Shuang Jun Xu
PRN | Corporate Officer/Principal | 55 | 11-02-28 |
Zhong Xi Cai
PRN | Corporate Officer/Principal | 59 | 10-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 10-04-30 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 19-01-10 |
Dong Jiu Li
BRD | Director/Board Member | 59 | 13-10-17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.58% | 4 M€ | -27.92% | ||
| 1.36% | 2 M€ | -12.32% | - | |
| 0.48% | 4 M€ | -11.56% | ||
| 0.47% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 21.95 | -1.57% | 4 241 901 |
| 24-05-16 | 22.3 | -1.11% | 5,481,640 |
| 24-05-14 | 22.55 | +1.35% | 8,171,275 |
| 24-05-13 | 22.25 | +3.49% | 8,191,657 |
| 24-05-10 | 21.5 | +3.61% | 8,433,489 |
Delayed Quote Hong Kong S.E., May 16, 2024 at 04:08 am EDT
More quotes
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.
Sector
Pharmaceuticals
Calendar
2024-06-12
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
20.63
CNY
Average target price
24.61
CNY
Spread / Average Target
+19.27%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +9.05% | 9.01B | |
| +20.04% | 71.69B | |
| -2.10% | 23.65B | |
| +10.34% | 8.64B | |
| -19.68% | 8.15B | |
| +13.68% | 5.33B | |
| +14.69% | 4.35B | |
| -1.04% | 4.1B | |
| -2.27% | 3.94B | |
| +25.30% | 3.81B |
- Stock Market
- Equities
- 1099 Stock
